Interestingly, a statistically significant increase in PINK1 and Parkin levels in the CSF paired with serum samples of patients with relapsing remitting (RR)MS in the acute phase highlight the importance of mitophagy in the etiopathogenesis and progression of MS (Cossu et al., 2021). The gene discussed is PRKN; the disease is myeloid sarcoma.